The utility of PSA for detection of prostate cancer in men treated with dutasteride: results from the reduction by dutasteride of prostate cancer events (REDUCE) study

  • G Andriole (Contributor)
  • D Bostwick (Contributor)
  • O Brawley (Contributor)
  • L Gomella (Contributor)
  • M Marberger (Contributor)
  • F Montorsi (Contributor)
  • P Pettaway (Contributor)
  • Tammela, T. (Contributor)
  • T Teloken (Contributor)
  • D Tindall (Contributor)
  • T Wilson (Contributor)
  • M Somerville (Contributor)
  • I Fowler (Contributor)
  • R Rittmaster (Contributor)

    Activity: Talk or presentationConference presentation

    Description

    Contributors: Andriole G, Bostwick D, Brawley O, Gomella L, Marberger M, Montorsi F, Pettaway P, TammelaT, Teloken T, Tindall D, Wilson T, Somerville M, Fowler I, Rittmaster R on behalf of the REDUCE study group
    Period26 Sept 2009
    Event titleThe Prostate Cancer Foundation 16th Annual Scientific Retreat 2009
    Event typeOther
    Degree of RecognitionInternational